Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Refractory Epilepsy With Thalidomide: an Open Trial

NCT01061866 is registered in ClinicalTrials.gov with National Institute of Neurology and Neurosurgery, Mexico as lead sponsor.

NCT NCT01061866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Refractory Epilepsy With Thalidomide: an Open Trial
Lead sponsor
National Institute of Neurology and Neurosurgery, Mexico
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2006
Completion date
January 31, 2008
Enrollment
7 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy